iLoF is an intelligent platform for precise, patient-centric drug development, providing a cloud-based library of optical fingerprints for non-invasive tracking, screening, and stratification in drug discovery.

iLoF

iLoF | 12,983 followers on LinkedIn. Using AI and Photonics to enable a new era of personalized, precision medicine. | iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development.

Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. 

Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported by leading institutions like Microsoft Ventures, Mayfield or the Oxford University, and has been regularly featured by outlets like Tech Crunch, Wired, or Sifted as a rising star in AI-Driven Drug Discovery, Health Screening &amp; Data Analytics.

Managing Partner

Shelly Bennecke

henkjan gersen

VP Product Engineer @ iLoF | Medical Device | IA & Photonics

Sandro Bordeira

CEO, Seedsight (Techstars '24) | Auxiliar Professor University of Porto | Sustainability, Social Impact, Photonics, AI & Digitalization, PhD | Forbes…

Joana S. Paiva

We are thrilled to be joining the most ambitious transnational Neurodegenerative Study named Bio-Hermes-002, led by Global Alzheimer's Platform Foundation , having secured a £1.2M (~$1.5M) contract from Innovate UK Contracts for Innovation to deploy our Optomics® platform in the groundbreaking Bio-Hermes-002 study 🚀💊 This international research, conducted by Global Alzheimer's Platform Foundation, aims to revolutionize Alzheimer's diagnosis and treatment by evaluating digital and blood-based biomarkers in over 1,000 participants across the US 🇺🇸, Canada 🇨🇦, and the UK 🇬🇧. The Global Alzheimer's Platform Foundation is a US patient-centric institution, partnering with leading philanthropic organizations like Gates Ventures or industry partners such as Roche , to Janssen Inc. or Eli Lilly and Company to accelerate the delivery of innovative therapies for neurological disorders. As part of the study, iLoF will be deploying iLoF’s breakthrough Optomics® platform, its AI-powered technology that combines photonics and multimodal data analysis, providing rapid, non-invasive, and cost-effective screening. In this international expansion, iLoF's US operation will be supported by Luminate Accelerator — the world's largest accelerator for startups specializing in optics, providing strategic capital and access to state-of-the-art lab facilities in Rochester, further advancing the platform deployed in the study. It’s with humbleness and a great sense of responsibility that we join forces with other organizations to accelerate our understanding of this condition, furthering our part in fighting Alzheimer’s ⚡ To learn more about Bio-Hermes-002 and our role in the study, visit the following link: https://lnkd.in/daKKPXZc --- #AlzheimersResearch #HealthTech #Innovation #RevolutionizingHealthcare #startup #PersonalizedMedicine #DiseaseTracking #DigitalHealth #PredictiveAnalysis #AI #Photonics #AllBiomarksHaveAFingerprint #iLoF

We are proud to share that our COO, Mehak Mumtaz , has been selected to be part of the inaugural 2024 Female Founders cohort, organized by the Department for Business and Trade , the UK’s government department for international investment and business! 🎉 This initiative addresses the challenges women face in securing investment. With only 3.5% of all venture funding in the UK going to female-led businesses in the first half of 2023, this programme aims to empower the country’s top female tech founders. As part of this prestigious cohort, our COO will gain access to a global network of investors, mentors, and new business opportunities, enabling to continue driving iLoF’s mission forward. 🌍💡 Congratulations to all the talented women in this year's cohort: Nadia Sood from CreditEnable | Amber Michelle H. from R.grid | Louise Birritteri from Pikl Insurance | Peony Li from Jude | Siddhi Mittal from yhangry | Susan Graham from Dendra Systems | Melissa Snover from REM3DY Health Group | Saasha Celestial-One & Tessa Clarke from Olio • Share More, Waste Less | May Rezai, PhD FRSA from MirZyme Therapeutics Your leadership is truly paving the way for a more inclusive and innovative future! #WomenInTech #FemaleFounders #HealthTech #AI #Photonics #DrugDiscovery #PersonalizedMedicine #iLoFTech #DigitalHealth

We are excited to announce a strategic investment from Hamamatsu Ventures Japan, a global leader in the development and manufacturing of photonic devices and systems for medical optics and biophotonics, as part of a collaboration to advance the future of personalized medicine. 🚀🧪 This collaboration between iLoF and Hamamatsu aims to be a major milestone in advancing the future of personalized medicine, combinung iLoFs cutting-edge AI-powered Optomics® technology with Hamamatsu’s expertise in photonics. Together, we hope will enhance precision diagnostics, accelerate early-stage patient identification, and expand into key markets including the U.S. and Japan. Moto Suyama, CTO of Hamamatsu Ventures, shared: “We understand that personalized medicine represents the future of healthcare innovation. We've been impressed with iLoF and the potential of their technology to accelerate early screening, and through investment, we hope to further explore synergies to transform the discovery of treatments for complex diseases and reshape how we approach diagnosis and drug discovery”. This strategic collaboration will push the boundaries of healthcare, with a shared vision to improve diagnostics and treatment for complex diseases. Press release: https://lnkd.in/gzy5_qJm Adnan Quazi | David Castrillo Sanz | Hamamatsu Corporation --- #Innovation #PersonalizedMedicine #AI #Photonics #StrategicPartnership #GlobalExpansion #iLoF #Hamamatsu

We are honored to share that iLoF has been recognized with the Outstanding Graduate Award, securing 2nd place in the Luminate finals, the best and biggest optics and photonics scale-up program in the world. 🇺🇸 This recognition comes after a rigorous technical, market, and business due diligence process conducted by the Luminate Advisory Board, composed of globally renowned experts. It marks a significant milestone for iLoF, as we continue to push the boundaries of photonics and AI for healthcare innovation. NextCorps ’s Luminate, often hailed as the YCombinator of Photonics & Optics, is based in the Optics and Photonics center of the USA—Rochester, NY, where 60-70% of the nation’s PhDs in optics are produced. 📈 This achievement also coincides with the expansion of our presence in the U.S., further fueling our mission to revolutionize the future of healthcare through advanced photonics and AI technology. We extend our deepest thanks to program/event sponsor, Optica , its funder, the Empire State Development , and the Luminate Accelerator team for their invaluable support throughout the program: Sujatha Ramanujan , Damon Diehl , Anjali Boriya , Veronica LoCurcio, Holly Barrett , Natalie Antal , Kate Leonard A special thank you also to the Luminate Advisory Board and mentors: Thomas Brown , Jenifer Bunis , Milton Chang , Stuart Elby , Stephen Fantone , Donald Golini , Mike J., Jay Kumler , Duncan Moore , Paul Pickering , Ryne Raffaelle , N Darius Sankey , James Senall , Linda Smith , Marc Tricard , and Edward White as all the experts who have guided us on this journey. Finally, a huge congratulations to our fellow finalists—we’re proud to be in such incredible company! AI Optics ; cureVision GmbH ; Enlipsium ; Nicslab ; Photosynthetic ; Q-Block Computing Inc. ; SaferStreet Solutions ; SeeTrue Technologies ; VoxelSensors . #iLoF #LuminateAccelerator #OutstandingGraduate #Photonics #Optics #HealthcareInnovation #RochesterNY #LuminateCohort7 #TechInnovation

Proud to share that iLoF has been highlighted in the Rochester Business Journal ! 🎉 The Journal has for decades been the leading outlet for business news and information in Rochester and New York, covering a wide range of areas from business to technology - now highlighting how our groundbreaking AI-powered photonics platform is transforming the clinical trial process 🚀 A big thank you to Rochester Business Journal for the feature - a significant boost as we push the boundaries of personalized medicine and accelerate drug discovery. Read the full online article here: https://lnkd.in/drBCbaRS Luminate Accelerator I NextCorps #HealthTech #AI #Photonics #DrugDiscovery #PersonalizedMedicine #iLoFTech #LuminateNY #Luminate #NextCorps

We are thrilled to announce that we have been selected as a finalists in the Scaleup category for the Santander X Global Challenge | Innovation in Healthcare! 🎉 This prestigious challenge, organized by Santander in collaboration with the Oxentia Foundation , seeks out companies driving innovation in healthcare—creating solutions that enhance efficiency, reduce costs, and improve overall healthcare systems. The selection of finalists and winners is expertly supported by Hitachi , a global leader in technology. 🌍 We couldn't be prouder of this recognition! Stay tuned as the final announcement is coming soon! 🚀 Finalists: Scaleups Mendelian ; NEOS Surgery ; iLoF ; Cero (YC S21) ; Axial3D ; Abi ; CanCertain ; Bitbrain ; NIMBLE Diagnostics ; HEURISTIK . Startups MedBrain ; BioTryp Therapeutics ; AI Rehab Ltd ; Labplus ; iYoni App ; Cardiology Devices Ltd ; acceXible ; bio.logis digital health GmbH ; FEYENALLY ; Hibi --- #iLoF #InnovationInHealthcare #SantanderXChallenge #HealthcareInnovation #Scaleup #OxentiaFoundation #Hitachi

Happy to have graduated from the Unicorn Factory Lisboa #ScalingUp Program! This prestigious program connects scale-ups and high-potential businesses with top coaches to achieve outstanding market success. We were fortunate to receive mentorship from industry leaders like Steve Cadigan , LinkedIn’s first “Chief People Officer.” Last month, our CEO, Luis Valente , had the honor of receiving the certificate from Carlos Moedas , Mayor of Lisbon, and Gil Azevedo , the driving forces behind the program. We’re excited to be part of this vibrant community of visionaries and change-makers within the Portuguese entrepreneurial ecosystem. Collaborating with such innovative people fills us with entalso wish the best of luck to the companies of the 5th cohort! Thank you to Unicorn Factory Lisboa for this incredible opportunity. The best is yet to come! 🚀 #HealthcareInnovation #DrugDiscovery #AI #PersonalizedMedicine #Leadership

Excited to share that we've been featured on the "Exploring Artificial Intelligence in Oncology" podcast with Dr. Waqas Haque ! In this episode, our CEO Luis Valente discusses how iLoF is harnessing the power of AI to revolutionize drug discovery and development. From accelerating the process to tailoring treatments for individual patients, this conversation delves into the future of personalized medicine and our commitment to innovation in healthcare. 🌟 Luís and Dr. Haque also explore the integration of AI in medical practice and the importance of staying up-to-date with the latest scientific literature. Our gratitude goes to the amazing Fellows Forum community, and to Dr. Waqas Haque for the insightful chat and interview. Don't miss out on this exciting discussion! Listen to the full episode here: https://lnkd.in/gVCXx4Tn #HealthcareInnovation #DrugDiscovery #AI #PredictiveAnalysis #Photonics #PersonalizedMedicine #Leadership #OncologyDataAdvisor #HealthTech #DigitalHealth #AllBiomarksHaveAFingerprint

What a journey! 🚀 Over the past few months, iLoF has kept it's momentum charting an exciting path, making our mark at some of the most prestigious healthtech events! Here’s a glimpse of where we’ve been and the exciting experiences we’ve had: 🇮🇪 Dublin Tech Summit Luis Valente , our CEO & Co-Founder, represented iLoF in a panel on leveraging technology to revolutionize healthcare, together with other passionate stakeholders. 🇬🇧 London Tech Week Luis was back in action at London Tech Week , highlighting our groundbreaking research and forging valuable connections with potential partners and investors - we’re excited about the future collaborations this could lead to! 🇨🇦 Collision Solidifying our global presence, Mehak Mumtaz , our COO & Co-Founder, took the stage again at one of the world’s largest tech conferences, Collision Conf , to showcase our personalized medicine solution and the future of healthcare 🚀 🇬🇧 NIHR HealthTech Research Centre in Brain Health Represented by Sara Rocha , our Senior Product Manager, we've had the opportunity to engage with potential research collaborators and highlighting the value of our work in this field 👩🔬 🇵🇹 Congress at CUF - Hospitais e Clínicas With an amazing presentation at the #OrthopedicsCongress , Sara Rocha demonstrated our product’s unique value proposition for healthcare professionals eager to implement innovative technologies in their practices! 🩺 These experiences have been instrumental in building traction, fostering potential partnerships, and enhancing our network - and make us even more committed to driving healthcare innovation! #iLoF #HealthTech #Innovation #DublinTechSummit #LondonTechWeek #Collision #NIHR #CUF #TechConference #BrainHealth #HealthcareInnovation

It was great to be back at #SouthSummit '24! We had a blast attending South Summit , an event that connects startups, investors, top leaders of the tech industry and where so valuable business relationships are forged! 🚀🌍 Sharing our vision with such a passionate and engaged group was a highlight of our journey. Luis Valente , CEO of iLoF , shared his experiences and insights on our revolution to use AI and photonics to breaking down the barriers to the development of personalized medicines, during the panel discussion "Beyond the Lab: Biotech in Healthcare" moderated by Dr. Siddharth Agrawal ( Labplus ) and also featuring Elena Sanchez Viñes ( Amadix ) and Daniel Ferrer Cid ( CARDIA by Apolo ) We’re leaving South Summit with valuable connections, a renewed excitement and a great eager to continue driving innovation in our exciting journey ahead! 🚀 See our panel discussion "Beyond the Lab: Biotech in Healthcare": https://lnkd.in/dWa99uTt --- #SouthSummit2024 #Innovation #TechTalk #Startups #Investors #Networking #iLoF #TechDisruption #FutureOfHealth #HealthTech #DrugDiscovery #InnovationLeadership #DataScience #DeepTech #Startup #Photonics #AI #Medicine #PrecisionMedicine

news impact assignment basic	general
public peers	general	Nov 9, 2024 7:48 AM	066e3357
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 9, 2024 7:48 AM	653cfbfe
crunchbase trigger	general	Nov 27, 2024 12:50 PM	d16ea505
crunchbase profile	general
li profile	general	Nov 9, 2024 7:48 AM	4f836080
translate crunchbase fundingrounds	general
peers	general	Nov 9, 2024 7:48 AM	ea9a5199
news basic	general	Nov 9, 2024 7:48 AM	9c81f20b
bundesanzeiger	filings
financials download nd	financials
private financials	financials

ILOF

TECH:ILOF

iLoF